Home

Biologics for Dental Providers.

Exosomes and Wharton’s Jelly for oral surgery, implant procedures, and periodontal applications, applied at provider discretion within your existing scope of practice.

The dental provider’s scope is expanding.

Dentists see patients more regularly than their primary care physicians. State legislation around biologics in dental practice is actively evolving, and providers who understand what’s available and what’s compliant within their scope are ahead of where the market is going.

Regenerative Dentistry

How Biologics Apply in Dental Practice

Oral Surgery Recovery

Exosomes and Wharton’s Jelly applied at extraction and surgical sites. ECM components and growth factors are homologous to those naturally present in oral tissue.

Implant Site Preparation

Wharton’s Jelly applied at implant sites prior to or during placement. Natural collagen and ECM matrix are homologous to components naturally present in alveolar tissue.

Bone Grafting Support

GEE+ and GEE-A applied in conjunction with bone grafting procedures at provider direction. Extracellular matrix components are homologous to those naturally present in bone and connective tissue.

Periodontal Procedures

Applied in conjunction with periodontal treatment at provider discretion. Contains natural human-derived hyaluronic acid and collagen components homologous to those present in healthy gingival tissue.

Socket Preservation

Wharton’s Jelly applied at extraction sites at provider direction. ECM scaffolding is homologous to components naturally present in the post-extraction site environment.

Aesthetic Dental Procedures

Exosomes applied in conjunction with soft tissue aesthetic procedures. Contains the building blocks naturally present in healthy oral tissue, which decline with age.

Revenue Potential

Model the financial impact of adding regenerative biologics to your dental practice.

$300–1.5K
Avg Ticket
10–25
Monthly Volume
$36–450K
Annual Potential

Products for Dental Practices

Exosomes
  • ~35B–350B exosomes per cc
  • 300+ biologically active cytokines and growth factors
  • Natural human Klotho
  • Human-derived hyaluronic acid
  • Chondroitin sulfate
Wharton's Jelly
  • 200+ biologically active cytokines and growth factors
  • Natural collagens
  • Human-derived hyaluronic acid
  • Chondroitin sulfate
FDA
FDA Registered
cGMP
cGMP Facility
ISO
Class 5 & 7 Cleanroom
MoCRA
MoCRA Compliant
Ethically Sourced

Ready to integrate biologics into your dental practice?

Get access to our full product catalog, state-specific compliance guides, and clinical resources, built for providers who want to know exactly what’s legal in their state before they start.

Built by AUSTAN

DISCLAIMER

Sōlix does not own, operate, or manage any laboratory, manufacturing, or compounding facility. All biological products available through this platform are manufactured, processed, and distributed by our independently owned and operated FDA-registered laboratory partners. Sōlix does not distribute, ship, handle, or take possession of any biological product at any point in the supply chain.

Sōlix operates as a provider platform that offers licensed healthcare practitioners access to product ordering, clinical education, implementation support, marketing resources, and business integration tools designed to help practices incorporate regenerative biologics into their clinical offerings.

Sōlix is not a compounding pharmacy or chemical compounding facility as defined under Section 503A or 503B of the Federal Food, Drug, and Cosmetic Act. Sōlix does not compound, manufacture, repackage, or relabel any drug or biological product.

Sōlix resources are for educational and informational purposes only. Providers are responsible for their own regulatory compliance, licensing, and insurance. Sōlix assumes no liability for how materials are applied in practice.

FDA DISCLAIMER

The statements made on this website have not been evaluated by the U.S. Food and Drug Administration. The products and services referenced on this platform are not intended to diagnose, treat, cure, or prevent any disease or medical condition. Biological products, including but not limited to stem cells, exosomes, Wharton's Jelly, and amniotic tissue allografts, are minimally manipulated human cells, tissues, and cellular and tissue-based products (HCT/Ps) regulated under 21 CFR Part 1271. These products are intended for homologous use only and are administered at the sole discretion of a licensed healthcare provider following individual patient assessment. Results may vary. No guarantees of specific outcomes are made or implied.

All medical decisions, including the use of regenerative biologics, should be made in consultation with a qualified healthcare professional. Sōlix makes no medical claims and assumes no liability for clinical outcomes resulting from the use of products ordered through this platform.

Sōlix provides a provider platform and sales CRM for ordering regenerative human biologics, managing provider relationships, and integrating third-party services including Google Calendar for scheduling and appointment management. For details on how we handle your data, see our Privacy Policy.

Terms & ConditionsPrivacy Policy